Search research articles
Contact Us
Filters
Showing results (61-70 of 135) with videos related to
Page
of 14
Sort By:
Molecular Cancer Therapeutics
|
August 19, 2007
Colon cancer chemoprevention by a novel NO chimera that shows anti-inflammatory and antiproliferative activity in vitro and in vivo
Ghenet K Hagos, Robert E Carroll, Tatiana Kouznetsova, et al.
Ebiomedicine
|
March 22, 2021
Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development
Cutler T Lewandowski, Md Wasim Khan, Manel BenAissa, et al.
The Journal of Biological Chemistry
|
December 20, 2015
Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein
Irida Kastrati, Marton I Siklos, Esther L Calderon-Gierszal, et al.
Nitric Oxide : Biology and Chemistry
|
May 20, 2008
Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionality
Tareisha Dunlap, Samer O Abdul-Hay, R Esala P Chandrasena, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
October 14, 2016
Time-Gated Detection of Cystathionine γ-Lyase Activity and Inhibition with a Selective, Luminogenic Hydrogen Sulfide Sensor
Yao Yao, Chen Kong, Liang Yin, et al.
Journal of Medicinal Chemistry
|
January 25, 2017
Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer
Rui Xiong, Jiong Zhao, Lauren M Gutgesell, et al.
Advances in Experimental Medicine and Biology
|
May 24, 2008
Estrogenic activity of the equine estrogen metabolite, 4-methoxyequilenin
Minsun Chang, Cassia R Overk, Irida Kastrati, et al.
Journal of Molecular Biology
|
July 6, 2007
Structural and functional analysis of two glutamate racemase isozymes from Bacillus anthracis and implications for inhibitor design
Melissa May, Shahila Mehboob, Debbie C Mulhearn, et al.
The Journal of Biological Chemistry
|
January 23, 2009
Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus
Zhican Wang, Gihani T Wijewickrama, Kuan-Wei Peng, et al.
Frontiers in Pharmacology
|
June 26, 2026
Inhibition of pathogenic tau signaling via blocking of the phosphatase-activating domain by novel small molecules
Raghad Nowar, Ganga Reddy Velma, Jiqiang Fu, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 135) with videos related to
Sort By:
Page
of 14
Molecular Cancer Therapeutics
|
August 19, 2007
Colon cancer chemoprevention by a novel NO chimera that shows anti-inflammatory and antiproliferative activity in vitro and in vivo
Ghenet K Hagos, Robert E Carroll, Tatiana Kouznetsova, et al.
Ebiomedicine
|
March 22, 2021
Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development
Cutler T Lewandowski, Md Wasim Khan, Manel BenAissa, et al.
The Journal of Biological Chemistry
|
December 20, 2015
Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein
Irida Kastrati, Marton I Siklos, Esther L Calderon-Gierszal, et al.
Nitric Oxide : Biology and Chemistry
|
May 20, 2008
Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionality
Tareisha Dunlap, Samer O Abdul-Hay, R Esala P Chandrasena, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
October 14, 2016
Time-Gated Detection of Cystathionine γ-Lyase Activity and Inhibition with a Selective, Luminogenic Hydrogen Sulfide Sensor
Yao Yao, Chen Kong, Liang Yin, et al.
Journal of Medicinal Chemistry
|
January 25, 2017
Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer
Rui Xiong, Jiong Zhao, Lauren M Gutgesell, et al.
Advances in Experimental Medicine and Biology
|
May 24, 2008
Estrogenic activity of the equine estrogen metabolite, 4-methoxyequilenin
Minsun Chang, Cassia R Overk, Irida Kastrati, et al.
Journal of Molecular Biology
|
July 6, 2007
Structural and functional analysis of two glutamate racemase isozymes from Bacillus anthracis and implications for inhibitor design
Melissa May, Shahila Mehboob, Debbie C Mulhearn, et al.
The Journal of Biological Chemistry
|
January 23, 2009
Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus
Zhican Wang, Gihani T Wijewickrama, Kuan-Wei Peng, et al.
Frontiers in Pharmacology
|
June 26, 2026
Inhibition of pathogenic tau signaling via blocking of the phosphatase-activating domain by novel small molecules
Raghad Nowar, Ganga Reddy Velma, Jiqiang Fu, et al.
Page
of 14